Diana Hausman
CIK: 0001563992
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMRX
Immuneering Corp
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 11, 2026IMRX
Immuneering Corp
Award(A)DirectStock Option
33.4K shares- - Jul 2, 2025IMRX
Immuneering Corp
Purchase(P)Direct2.5K shares at avg. $3.60$9K - Jul 2, 2025IMRX
Immuneering Corp
Purchase(P)Indirect3K shares at avg. $3.62$11K - Jun 13, 2025IMRX
Immuneering Corp
Award(A)DirectStock Option
33.4K shares-
1-4 of 4 transactions
About HAUSMAN DIANA
HAUSMAN DIANA (SEC CIK 0001563992) files insider reports with the SEC as Director of Immuneering Corp (IMRX).
Signal8 holds 3 ownership filings by HAUSMAN DIANA, all Form 4s, filed between Jun 16, 2025 and Jun 11, 2026. Those filings report 4 transactions, from Jun 13, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HAUSMAN DIANA's filings is in CAMBRIDGE, MA.
Recent filings by HAUSMAN DIANA
Other insiders filing for Immuneering Corp (IMRX)
- Gengos Andrew, Chief Financial Officer
- Zeskind Benjamin J., PRESIDENT AND CEO
- Hall Brett Matthew, CHIEF SCIENTIFIC OFFICER
- Schall Thomas J., Director
- CARPENTER ROBERT J, Director
- KEATING LAURIE, Director